Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis/polymyositis

Clinical and Experimental Immunology

Volumn 129, Issue 3, 2002, Pages 541-548

  Kurasawa, K ^a   Nawata, Y ^a   Takabayashi, K ^a   Kumano, K ^a   Kita, Y ^a   Takiguchi, Y ^a   Kuriyama, T ^a   Sueishi, M ^b   Saito, Y ^a   Iwamoto, I ^a  

^a CHIBA UNIVERSITY   (Japan)

^b SHIMOSHIZU HOSPITAL   (Japan)

Author keywords

Bronchoalveolar lavage fluids; CD25+ T cells; Corticosteroid resistant interstitial pneumonitis; Dermatomyositis polymyositis; IFN producing T cells

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 4; MESSENGER RNA; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; INTERSTITIAL PNEUMONIA; LEUKOCYTE COUNT; MALE; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; T LYMPHOCYTE ACTIVATION; TH1 CELL; TREATMENT OUTCOME;

BRONCHOALVEOLAR LAVAGE FLUID; DERMATOMYOSITIS; DRUG RESISTANCE; FEMALE; GLUCOCORTICOIDS; HLA-DR ANTIGENS; HUMANS; INTERFERON TYPE II; LUNG; LUNG DISEASES, INTERSTITIAL; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; POLYMYOSITIS; PREDNISOLONE; RECEPTORS, INTERLEUKIN-2; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 18544381670     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01933.x     Document Type: Article

References (27)

1. Interstitial pneumonitis in association with polymyositis and dermatomyositis
2. Interstitial lung disease in polymyositis and dermatomyositis
3. Polymyositis and diffuse interstitial lung disease
4. Pulmonary disease in polymyositis/dermatomyositis
5. Pulmonary disease in polymyositis/dermatomyositis. A clinicopathological analysis of 65 autopsy cases
6. Interstitial lung disease in dermatomyositis: Clinicopathological study
7. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings
8. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis. Prediction and treatment with cyclosporine
9. Cyclosporine treatment of steroid-resistant interstitial pneumonitis associated with dermatomyositis/polymyositis
10. Cyclosporine treatment for polymyositis/dermatomyositis: Is it possible to rescue the deteriorating cases with interstitial pneumonitis?
11. Polymyositis and dermatomyositis
12. Interstitial lung disease. Current concepts of pathogenesis, staging and therapy
13. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases
14. Workshop summary and guidelines. Investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseases
15. Sequential expression of T cell activation (Tac) antigen and Ia determinants on circulating human T cells after immunization with tetanus toxoid
16. + T lymphocyte in experimental lung disease
17. Lung injury induced by alloreactive Th1 cells is characterized by host-derived mononuclear cell inflammation and activation of alveolar macrophages
18. Gamma interferon priming of mouse and human macrophages for induction of tumor necrosis factor production by bacterial lipopolysaccharide
19. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity
20. Macrophage priming by interferon-γ, a selective process with potentially harmful effects
21. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon
22. Tumor necrosis factor combines with IL-4 or IFN-γ to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms
23. Glucocorticoid-induced inhibition of T cell growth factor production I. The effect on mitogen-induced lymphocyte proliferation
24. Spontaneous and glucocorticoid-induced apoptosis in human mature T lymphocytes
25. Rescue of thymocytes and T cell hybridomas from glucocorticoid-induced apoptosis by stimulation via the T cell receptor/CD3 complex: A possible in vitro model for positive selection of the T cell repertoire
26. + subsets
27. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance